Karam Sammy 4
4 · ABBOTT LABORATORIES · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-04-27$75.90/sh+8,600$652,740→ 31,526 total - Sale
Common shares without par value
2021-04-27$122.00/sh−8,600$1,049,200→ 22,926 total - Exercise/Conversion
Option (right to buy)
2021-04-27−8,600→ 72,978 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common Shares (8,600 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.